Expression-Based GWAS Reveals Role for Immune Cell Receptor in T2D | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – In a study set to appear online this week in the Proceedings of the National Academy of Sciences, researchers from the US and Japan report that they have linked an immune-cell receptor called CD44 to type 2 diabetes using an expression-based genome-wide association study, or eGWAS, strategy.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.